Merck & Co., Inc. MRK NYSE

Merck & Co., Inc. (MRK) has shown moderate revenue growth over the past 3 years, expanding from $59.3B to $65.0B (average +3.2%/yr). Net income reached $18.3B, reflecting exceptional earnings expansion at +1499.6%/yr on average. The net profit margin is 28.1%, which is exceptional. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 81.5% (high), with a +10.9pp trend over the period. With a $297B market cap and MOAT composite score of 94/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (73/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year history, the company was profitable in 41 of 41 years — a perfect long-term track record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (94/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 83/100 with 7/7 criteria passed.